Benicar

Florida Benicar Attorneys

Paul-Perkins-199x300Benicar is a prescription drug used to treat high blood pressure. However, many Benicar users have reported severe intestinal symptoms similar to those experienced during Celiac disease. These users have filed a number of lawsuits to seek financial compensation from the manufacturer, Daiichi Sankyo.

What Is Benicar?

Benicar (olmesartan medoxomil) received FDA approval in 2002 to treat high blood pressure. The drug has also been marketed as Benicar HCT, Tibenzor, and Azor, as well as generics. Benicar and its sister drugs are angiotensin II receptor blockers, more commonly known as ARBs.

They are typically taken alone or in conjunction with other antihypertensive agents. As of 2014, there are only eight ARB drugs on the market for treating high blood pressure. However, Benicar and other drugs containing olmesartan are the only drugs known to produce severe side effects known as sprue-like enteropathy.

Benicar Side Effects

Individuals taking Benicar have been known to develop Sprue-like enteropathy. Sprue-like enteropathy refers to a series of severe gastrointestinal issues. Most notably, patients who suffer the condition experience severe and chronic diarrhea alongside significant weight loss. A number of patients have required hospitalization.

Patients have reported Benicar side effects from time periods ranging from months to years after beginning to take the drug. Benicar patients who experience unexplained gastrointestinal issues should seek medical attention immediately, including discussion of discontinuing Benicar. Some former users have reported a decrease in sprue-like enteropathy symptoms after discontinuing the drug.

Benicar sprue-like enteropathy symptoms may include:

  • Chronic diarrhea
  • Intestinal damage
  • Severe weight loss requiring hospitalization
  • Malnourishment

Villous Atrophy

Villous atrophy is another known side effect of Benicar and other olmesartan drugs. Villous atrophy is a medical condition that affects the intestinal lining. Patients with the condition experience texture loss along the intestinal walls, which results in difficulty absorbing nutrients.

FDA Warning

In July 2013, the U.S. Food and Drug Administration released an official warning to consumers regarding the risk of sprue-like enteropathy and other gastrointestinal side effects of Benicar and its sister drugs. Along with this warning came approval of label changes for the drug’s packaging in order to better inform current and potential Benicar patients.

Legal Complaints

A number of individuals have filed lawsuits against Daiichi Sankyo in hopes of earning financial compensation through a Benicar lawsuit. The first lawsuits were filed in February 2014 the Jersey state court system. After the initial lawsuits were filed, the cases were moved to federal court. Specialists and experts predict that more lawsuits against Daiichi Sankyo will continue to be filed.

Legal claims against Daiichi Sankyo include:

  • Selling and promoting “defective and unreasonably dangerous” products to consumers
  • Concealing Benicar’s dangers from the public, thus risking the lives of consumers
  • Failing to warn the public and medical professionals of the severe side effect risks
  • Inadequate testing prior to selling and distributing Benicar
  • Creating and selling a dangerous drug despite knowledge of its potential harm
  • Negligent and malicious disregard for consumer rights
  • False and misleading advertising claims that Benicar is safe and effective

Filing a Benicar Lawsuit

Benicar patients who experience sprue-like enteropathy, villous atrophy, or other severe gastrointestinal side effects should explore their options to file a legal claim. Depending on the outcome of the case, these patients may receive compensation for the harm caused to them by Daiichi Sankyo’s drug. Compensation may be awarded to cover medical bills and other related costs, as well as compensation for non-financial loss like pain, suffering, and loss of quality of life.

Hiring a Benicar Lawyer

Before filing a Benicar lawsuit, patients should speak with a knowledgeable and experienced drug litigation attorney. The attorney can help evaluate medical records and other circumstances surrounding the client’s situation to determine if the case is valid and has a viable chance of succeeding in court. A Benicar lawyer can also provide insight, advice, and guidance throughout the legal process to help alleviate some of the stress associated with the ordeal.

 

Sources:

DeGaetani, Marisa, et. al. “Villous Atrophy and Negative Celiac Serology: A Diagnostic and Therapeutic Dilemma.” American Journal of Gastroenterology 108.1 (2013): 647-53. Print.

“FDA Drug Safety Communication: FDA Approves Label Changes to Include Intestinal Problems (sprue-like Enteropathy) Linked to Blood Pressure Medicine Olmesartan Medoxomil.” U.S. Food and Drug Administration. U.S. Department of Health and Human Services, 3 July 2013. Web. 10 Oct. 2014.

Rubio-Tapia, Alberto, et. al. “Severe Spruelike Enteropathy Associated with Olmesartan.” Mayo Clinic Proceedings 87.8 (2012): 732-38. Print.